334 related articles for article (PubMed ID: 26469867)
21. Fetal and neonatal alloimmune thrombocytopenia.
van den Akker ES; Oepkes D
Best Pract Res Clin Obstet Gynaecol; 2008 Feb; 22(1):3-14. PubMed ID: 17936686
[TBL] [Abstract][Full Text] [Related]
22. Low-avidity HPA-1a alloantibodies in severe neonatal alloimmune thrombocytopenia are detectable with surface plasmon resonance technology.
Socher I; Andrei-Selmer C; Bein G; Kroll H; Santoso S
Transfusion; 2009 May; 49(5):943-52. PubMed ID: 19175553
[TBL] [Abstract][Full Text] [Related]
23. The implementation of surface plasmon resonance technique in monitoring pregnancies with expected fetal and neonatal alloimmune thrombocytopenia.
Bakchoul T; Bertrand G; Krautwurst A; Kroll H; Bein G; Sachs UJ; Santoso S; Kaplan C
Transfusion; 2013 Sep; 53(9):2078-85. PubMed ID: 23278334
[TBL] [Abstract][Full Text] [Related]
24. A review of the contemporary management of fetal and neonatal alloimmune thrombocytopenia in an Australian tertiary obstetric hospital.
Cook TJ; Qiu CC; Dickinson JE
Aust N Z J Obstet Gynaecol; 2012 Aug; 52(4):321-6. PubMed ID: 22510050
[TBL] [Abstract][Full Text] [Related]
25. Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review.
Kamphuis MM; Paridaans N; Porcelijn L; De Haas M; Van Der Schoot CE; Brand A; Bonsel GJ; Oepkes D
BJOG; 2010 Oct; 117(11):1335-43. PubMed ID: 20618318
[TBL] [Abstract][Full Text] [Related]
26. Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach.
Lieberman L; Greinacher A; Murphy MF; Bussel J; Bakchoul T; Corke S; Kjaer M; Kjeldsen-Kragh J; Bertrand G; Oepkes D; Baker JM; Hume H; Massey E; Kaplan C; Arnold DM; Baidya S; Ryan G; Savoia H; Landry D; Shehata N;
Br J Haematol; 2019 May; 185(3):549-562. PubMed ID: 30828796
[TBL] [Abstract][Full Text] [Related]
27. Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model.
Tiller H; Killie MK; Chen P; Eksteen M; Husebekk A; Skogen B; Kjeldsen-Kragh J; Ni H
Transfusion; 2012 Jul; 52(7):1446-57. PubMed ID: 22251227
[TBL] [Abstract][Full Text] [Related]
28. Management of neonatal thrombocytopenia in a context of maternal antiplatelet alloimmunization: Expert opinion of the French-speaking working group.
Bertrand G; Blouin L; Boehlen F; Levine E; Minon JM; Winer N;
Arch Pediatr; 2019 Apr; 26(3):191-197. PubMed ID: 30827773
[TBL] [Abstract][Full Text] [Related]
29. Towards a prophylactic treatment of HPA-related foetal and neonatal alloimmune thrombocytopenia.
Kjeldsen-Kragh J; Ni H; Skogen B
Curr Opin Hematol; 2012 Nov; 19(6):469-74. PubMed ID: 22954726
[TBL] [Abstract][Full Text] [Related]
30. Current Anti-HPA-1a Standard Antibodies React with the β3 Integrin Subunit but not with αIIbβ3 and αvβ3 Complexes.
Bayat B; Traum A; Berghöfer H; Werth S; Zhu J; Bein G; Sachs UJ; Santoso S
Thromb Haemost; 2019 Nov; 119(11):1807-1815. PubMed ID: 31587244
[TBL] [Abstract][Full Text] [Related]
31. Generation of human antibodies targeting human platelet antigen (HPA)-1a.
Oosterhoff JJ; Linty F; Visser R; de Vos T; Hofstede-van Egmond S; van de Weerd M; Porcelijn L; de Haas M; van der Schoot E; Vidarsson G
Transfusion; 2024 May; 64(5):893-905. PubMed ID: 38400657
[TBL] [Abstract][Full Text] [Related]
32. Natural history of human platelet antigen 1a-alloimmunised pregnancies: a prospective observational cohort study.
de Vos TW; Winkelhorst D; Porcelijn L; Beaufort M; Oldert G; van der Bom JG; Lopriore E; Oepkes D; de Haas M; van der Schoot E
Lancet Haematol; 2023 Dec; 10(12):e985-e993. PubMed ID: 38407610
[TBL] [Abstract][Full Text] [Related]
33. Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT): Scientific Impact Paper No. 61.
Regan F; Lees CC; Jones B; Nicolaides KH; Wimalasundera RC; Mijovic A;
BJOG; 2019 Sep; 126(10):e173-e185. PubMed ID: 30968555
[TBL] [Abstract][Full Text] [Related]
34. HIP (HPA-screening in pregnancy) study: protocol of a nationwide, prospective and observational study to assess incidence and natural history of fetal/neonatal alloimmune thrombocytopenia and identifying pregnancies at risk.
Winkelhorst D; de Vos TW; Kamphuis MM; Porcelijn L; Lopriore E; Oepkes D; van der Schoot CE; de Haas M
BMJ Open; 2020 Jul; 10(7):e034071. PubMed ID: 32690731
[TBL] [Abstract][Full Text] [Related]
35. Will it ever be possible to balance the risk of intracranial haemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it?
Radder CM; Brand A; Kanhai HH
Vox Sang; 2003 May; 84(4):318-25. PubMed ID: 12757506
[TBL] [Abstract][Full Text] [Related]
36. Predicting risk severity and response of fetal neonatal alloimmune thrombocytopenia.
Salomon O; Rosenberg N
Br J Haematol; 2013 Aug; 162(3):304-12. PubMed ID: 23672281
[TBL] [Abstract][Full Text] [Related]
37. Anti-human platelet antigen-5b antibodies and fetal and neonatal alloimmune thrombocytopenia; incidental association or cause and effect?
Alm J; Duong Y; Wienzek-Lischka S; Cooper N; Santoso S; Sachs UJ; Kiefel V; Bein G
Br J Haematol; 2022 Jul; 198(1):14-23. PubMed ID: 35383895
[TBL] [Abstract][Full Text] [Related]
38. Antenatal intravenous immunoglobulins in pregnancies at risk of fetal and neonatal alloimmune thrombocytopenia: comparison of neonatal outcome in treated and nontreated pregnancies.
Ernstsen SL; Ahlen MT; Johansen T; Bertelsen EL; Kjeldsen-Kragh J; Tiller H
Am J Obstet Gynecol; 2022 Sep; 227(3):506.e1-506.e12. PubMed ID: 35500612
[TBL] [Abstract][Full Text] [Related]
39. Fetal/neonatal allo-immune thrombocytopenia (FNAIT): past, present, and future.
Serrarens-Janssen VM; Semmekrot BA; Novotny VM; Porcelijn L; Lotgering FK; Delemarre FM; Steegers EA
Obstet Gynecol Surv; 2008 Apr; 63(4):239-52. PubMed ID: 18348738
[TBL] [Abstract][Full Text] [Related]
40. Marked thrombocytopenia in a neonate is associated with anti-HPA-5b, anti-HLA-A31, and anti-HLA-B55 antibodies.
Okubo M; Nishida E; Watanabe A; Nishizaki N; Obinata K; Azuma F; Matsuhashi M; Watanabe-Okochi N; Tsuno NH; Miyake K; Yamaguchi M; Yoshida K; Ohsaka A
Pediatr Blood Cancer; 2019 Mar; 66(3):e27555. PubMed ID: 30488611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
